Race and Novel Prescription Drugs

Research by Essien and colleagues found that Black patients with atrial fibrillation were less likely to receive the newer class of DOAC blood thinner medications than White patients.


Race, Discrimination, and Health: 50 Years after MLK

Fifty years after Dr. Martin Luther King’s death, racism, discrimination, and prejudice continue to fill the national discourse, especially regarding healthcare. The social justice that Dr. King fought for remains critical to American health today.